CStone Pharmaceuticals · HKEX:2616

CStone Pharmaceuticals shareholders

CStone Pharmaceuticals on 6ix: holders from Hong Kong's register and US fund reports; insider trades reported in Hong Kong. Largest: WuXi Healthcare Management, LLC, WuXi Healthcare Ventures II, L.P. and Pfizer Inc. Each with its filing.

Shareholders

Register

HolderSharesOf the companyAs of
WuXi Healthcare Management, LLC173M11.8%Aug 20, 2025
WuXi Healthcare Ventures II, L.P.173M11.8%Aug 20, 2025
Pfizer Inc.116M7.9%Jul 16, 2025
HHLR Advisors, Ltd.88.7M5.6%Apr 22, 2026
Yang Jianxin84.8M5.3%Oct 26, 2026

Funds

HolderSharesValueChangeAs of
Vanguard Total International Stock Index Fund18.2MUS$10M+1.91MJul 31, 2026
Vanguard Emerging Markets Stock Index Fund17.3MUS$9.52M+1.79MJul 31, 2026
iShares Core MSCI Emerging Markets ETF14.3MUS$14.7M+806KMay 31, 2026
Vanguard Ftse All-World Ex-Us Small-Cap Index Fund5.25MUS$2.89M+1.1MJul 31, 2026
State Street(R) SPDR(R) Portfolio Emerging Markets ETF1.41MUS$844K−26,500Jun 30, 2026
iShares Core MSCI Total International Stock ETF921KUS$507KNewJul 31, 2026
Vanguard Total World Stock Index Fund879KUS$484KNo changeJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account687KUS$414KNo changeJun 30, 2026
Fidelity Total International Index Fund620KUS$341K−5,000Jul 31, 2026
State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF588KUS$353K−42,000Jun 30, 2026
iShares MSCI China Small-Cap ETF450KUS$462K−144KMay 31, 2026
iShares MSCI Emerging Markets Small-Cap ETF241KUS$248KNewMay 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio229KUS$137KNo changeJun 30, 2026
State Street(R) SPDR(R) S&P(R) China ETF135KUS$81,082−6,000Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Emerging Asia Pacific ETF34,000US$20,421+2,000Jun 30, 2026
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund22,500US$12,395No changeJul 31, 2026

CStone Pharmaceuticals insider trades